Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanne G J Mourmans

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
ESC Heart Failure|October 27, 2024
Prognostic value of hypoxaemic burden from overnight oximetry in heart failure with preserved ejection fractionSanne G J Mourmans, Jerremy Weerts, Mathias Baumert, et al.
Biomolecules|February 25, 2022
The Role of Systemic Microvascular Dysfunction in Heart Failure with Preserved Ejection FractionJerremy Weerts, Sanne G J Mourmans, Arantxa Barandiarán Aizpurua, et al.
European Journal of Preventive Cardiology|July 10, 2025
The diagnostic yield of an elaborate workup for comorbidities in a real-life HFpEF outpatient populationSanne G J Mourmans, Anouk Achten, Jerremy Weerts, et al.
Cardiovascular Diabetology|April 5, 2025
Temporal prevalence and prognostic impact of diabetes mellitus and albuminuria in heart failure with preserved ejection fractionNousjka P A Vranken, Xinyu Li, Heleen Bouman, et al.
ESC Heart Failure|December 2, 2024
Inter-atrial block as a predictor of adverse outcomes in patients with HFpEFJerremy Weerts, Sanne G J Mourmans, Helena Lopez-Martinez, et al.
Cardiovascular Diabetology|April 25, 2025
The effect of empagliflozin on peripheral microvascular dysfunction in patients with heart failure with preserved ejection fractionSanne G J Mourmans, Anouk Achten, Raquel Hermans, et al.
Journal of Clinical Medicine|April 13, 2024
Retinal Vascular Changes in Heart Failure with Preserved Ejection Fraction Using <i>Optical Coherence Tomography Angiography</i>Jerremy Weerts, Anne G Raafs, Birgit Sandhoefner, et al.
International Journal of Cardiology. Heart & Vasculature|February 10, 2025
Prevalence and prognostic value of ventricular conduction delay in heart failure with preserved ejection fractionAnouk Achten, Jerremy Weerts, Johan van Koll, et al.
European Journal of Heart Failure|April 6, 2025
Peroxiredoxin-4, a marker of systemic oxidative stress, is associated with incident heart failureNavin Suthahar, Sanne G J Mourmans, Anouk Achten, et al.
ESC Heart Failure|July 11, 2025
Immuno-haemostatic dysregulation in heart failure with preserved ejection fractionGiorgia D'Italia, Daniëlle M Coenen, Titus P Lemmens, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
ESC Heart Failure|October 27, 2024
Prognostic value of hypoxaemic burden from overnight oximetry in heart failure with preserved ejection fractionSanne G J Mourmans, Jerremy Weerts, Mathias Baumert, et al.
Biomolecules|February 25, 2022
The Role of Systemic Microvascular Dysfunction in Heart Failure with Preserved Ejection FractionJerremy Weerts, Sanne G J Mourmans, Arantxa Barandiarán Aizpurua, et al.
European Journal of Preventive Cardiology|July 10, 2025
The diagnostic yield of an elaborate workup for comorbidities in a real-life HFpEF outpatient populationSanne G J Mourmans, Anouk Achten, Jerremy Weerts, et al.
Cardiovascular Diabetology|April 5, 2025
Temporal prevalence and prognostic impact of diabetes mellitus and albuminuria in heart failure with preserved ejection fractionNousjka P A Vranken, Xinyu Li, Heleen Bouman, et al.
ESC Heart Failure|December 2, 2024
Inter-atrial block as a predictor of adverse outcomes in patients with HFpEFJerremy Weerts, Sanne G J Mourmans, Helena Lopez-Martinez, et al.
Cardiovascular Diabetology|April 25, 2025
The effect of empagliflozin on peripheral microvascular dysfunction in patients with heart failure with preserved ejection fractionSanne G J Mourmans, Anouk Achten, Raquel Hermans, et al.
Journal of Clinical Medicine|April 13, 2024
Retinal Vascular Changes in Heart Failure with Preserved Ejection Fraction Using <i>Optical Coherence Tomography Angiography</i>Jerremy Weerts, Anne G Raafs, Birgit Sandhoefner, et al.
International Journal of Cardiology. Heart & Vasculature|February 10, 2025
Prevalence and prognostic value of ventricular conduction delay in heart failure with preserved ejection fractionAnouk Achten, Jerremy Weerts, Johan van Koll, et al.
European Journal of Heart Failure|April 6, 2025
Peroxiredoxin-4, a marker of systemic oxidative stress, is associated with incident heart failureNavin Suthahar, Sanne G J Mourmans, Anouk Achten, et al.
ESC Heart Failure|July 11, 2025
Immuno-haemostatic dysregulation in heart failure with preserved ejection fractionGiorgia D'Italia, Daniëlle M Coenen, Titus P Lemmens, et al.
Pageof 2